P3 Health Partners Inc (PIII) Institutional Buying & Selling Tracker (Q2 2026)

PIII ranks #8394 out of 37569 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

PIII is a disclosed holding of Jane Street (Jane Street Group), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

20 institutions disclose a position in PIII, but none treat it as a major bet — even Scientech Research LLC, its most concentrated holder, allocates just 0.1% of its own portfolio to it.

Geode Capital Management, LLC has added to its PIII position for two straight quarters, increasing it by $109.7K to reach $184.7K today.

PIII is down 0.7% today, but institutions show net buying of $1.3M this quarter — a divergence between today's price move and the underlying institutional flow.

PIII reported a net loss of $98.4M over the trailing twelve months.

• Not yet profitable — net loss of $98.4M over the trailing twelve months
• Revenue grew 2.8% year over year
• Net income improved year over year, from -$146.0M to -$98.4M
• Operating cash flow was negative, using $91.2M in cash
• Current ratio of 0.24x — below the conventional 1.5x liquidity buffer
• Total liabilities currently exceed total assets (negative shareholder equity)